Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevirapine for Prevention of Maternal-Fetal HIV Transmission
NCT00000942Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Nevirapine with Placebo (2 arms). Primary endpoint: Rate of maternal-fetal HIV transmission at 6 months. Status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000942.